OraPharm’s own research institute has its origins in the research on probiotics
for oral health conducted by Dr. Oh Jong-Suk in the Medical School at Chonnam
National Univ. in 1997. The team led by Dr. Oh believed that probiotics would play
a promising role as a next-generation solution in oral management. They,
therefore, isolated probiotic strains which have beneficial effects on oral disease
prevention and management, adopted names for those strains, and finally found
that those strains have great potential for becoming a solution in oral management.
To continue further research and buckle down to make oral probiotics commercially
available, OraPharm was established in 2014 as a company specialized in
probiotics for oral health. The company has employed core members of
the research team led by Dr. Oh and has been doing various researches on
the oral cavity ever since.
59.4%
Reduction in bad breath
(46 participants,20.7%
Inhibition of plaque formation
(72 participants,18.4%
Plaque inhibition
(60 participants,18.5%
Reduction of bacteria that cause dental caries
(60 participants,Improvement of the
bad breath in 8 weeks
(60 participants,Improvement of the
bad breath in 8 weeks
(92 participants,Adhesive properties
Improved by 414%
after 8 weeks with
no probiotics intake
(60 participants,Reduction in gingival
bleeding index in 8 weeks
(92 participants,Efficacy in the Suppression of Halitosis | Efficacy in the Prevention of Caries | Inhibition of the Growth of Bacteria That Cause Halitosis | Efficacy in the Adhesion in Oral Cavity | Efficacy in the Prevention of Periodontitis | Inhibition of Factors Causing Inflammation of the Gums | ||
---|---|---|---|---|---|---|---|
Organoleptic level of halitosis | Concentration of VSC | Concentration of CH3SH | Dental plaque index | Bacteria associated with halitosis (Fn, Pg, Pi, Tf ) |
oraCMU (W.cibaria) |
Alveolar bone loss | TNα,ILß,IL6 |
Suppressed by 40.5% | Suppressed by 37.3% | Suppressed by 52.6% | Reduced by 30.6% | Inhibited by 58.8%~99.6% | Increased by 70.6% | Suppressed by 26.9% | Decreased by 120%, 110%, and 130% respectively |
Bacteria That Cause Halitosis·Periodontitis | Bacteria That Cause Periodontitis |
Bacteria That Cause Dental Caries |
Bacteria That Cause Halitosis·Periodontitis | Biofilm Formation Inhibition |
Efficacy in the Suppression of Halitosis (containing VSC) |
Efficacy in H2O2 Generation |
Coaggregation |
---|---|---|---|---|---|---|---|
P. gingivalis | A. actinomy cetemcomitans |
S. mutans | F. nucleatum | Biofilms formed by S. mutans |
H2S/CH3SH | H2O2 | Bacteria that cause halitosis·periodontitis (Fn, Td, Pi) |
Suppressed by 99.9% | Suppressed by 99.9% | Suppressed by 97.7% | Suppressed by 96.6% | Inhibited by 96.8% | 48.2%/59.4% | 3.91 mM | 66.5%~89.3% |
Date | Authorities Concerned | Name of the Project | Content |
---|---|---|---|
April 2020 | The Ministry of Agriculture, Food and Rural Affairs | Development of technology for industrialization of valuable agricultural bioresources | Efficacy assessment and product development of oral probiotics to prevent upper respiratory infections |
March 2018 | Korea Industrial Technology Association | Support for university - corporate research institute collaborative R&D | Clinical trials for verification of efficacy of probiotics for oral health purposes & functional food product development |
March 2018 | Korea Institute of Startup & Entrepreneurship Development | Startup Scale-Up Package | Turning the use of oraCMU®, the probiotics for the prevention and removal of bad breath, and the finished product(Green Breath) into a business |
December 2017 | Korea Technology and Information Promotion Agency for SMEs | Program for technological development by industries, universities, and public research institutes working in collaboration | Verification of ingredients for the probiotics for the prevention and improvement of periodontal diseases and development of prototypes of functional food |
December 2017 | Korea Health Industry Development Institute | 2017 Startup Scale-Up Package | Food and ingredients of probiotics for the prevention and improvement of halitosis |
December 2017 | Ministry of SMEs and Startups | Program for scaling up technological development | Verification of ingredients for the probiotics for the prevention and improvement of periodontal diseases and development of prototypes of functional food |
July 2017 | Kookmin University | BRIDGE + | Manufacturing a functional food product prototype, or more specifically, a probiotics prototype with anti-halitosis and anti-bacterial properties using Lean-DMADOV |
July 2016 | The Small and Medium Business Administration | Project to support the technology development and growth of startups | Development of next-generation probiotics for caries prevention |
December 2015 | Kookmin University | Prototype production support program by LINK+ | Developing and manufacturing an oral probiotics prototype |
Date | Authorities Concerned | Name of the Project | Content |
---|---|---|---|
April 2020 | The Ministry of Agriculture, Food and Rural Affairs | Development of technology for industrialization of valuable agricultural bioresources | Efficacy assessment and product development of oral probiotics to prevent upper respiratory infections |
Date | Authorities Concerned | Name of the Project | Content |
---|---|---|---|
April 2020 | The Ministry of Agriculture, Food and Rural Affairs | Development of technology for industrialization of valuable agricultural bioresources | Efficacy assessment and product development of oral probiotics to prevent upper respiratory infections |
March 2018 | Korea Industrial Technology Association | Support for university - corporate research institute collaborative R&D | Clinical trials for verification of efficacy of probiotics for oral health purposes & functional food product development |
Date | Authorities Concerned | Name of the Project | Content |
---|---|---|---|
April 2020 | The Ministry of Agriculture, Food and Rural Affairs | Development of technology for industrialization of valuable agricultural bioresources | Efficacy assessment and product development of oral probiotics to prevent upper respiratory infections |
March 2018 | Korea Industrial Technology Association | Support for university - corporate research institute collaborative R&D | Clinical trials for verification of efficacy of probiotics for oral health purposes & functional food product development |
March 2018 | Korea Institute of Startup & Entrepreneurship Development | Startup Scale-Up Package | Turning the use of oraCMU®, the probiotics for the prevention and removal of bad breath, and the finished product(Green Breath) into a business |
No | Citation | Journal | Research Level | Title | Date |
---|---|---|---|---|---|
1 | SCI | Mol Med Rep. 2020;22:4143-4150. |
in vitro study | Weissella cibaria CMU exerts an anti-inflammatory effect by inhibiting Aggregatibacter actinomycetemcomitans-induced NFκB activation in macrophages | 2020.09 |
2 | SCI | BMC Oral Health 2020;20:243. |
Clinical trial | Effects of probiotic bacterium Weissella cibaria CMU on periodontal health and microbiota: a randomized, double-blind, placebo-controlled trial | 2020.09 |
3 | SCI | J Med Food. 2020;23(6). | Clinical trial | Reduction of halitosis by a tablet containing Weissella cibaria CMU: A randomized, double-blind, placebo-controlled study | 2020.06 |
4 | SCI | J Periodontol. 2020;3. | in vivo study | Effect of W. cibaria on the reduction of periodontal tissue destruction in mice | 2020.02 |
5 | KCI | Int J Oral Biol. 2019;44:152-159. |
in vitro study | Weissella cibaria CMU suppresses mgl gene expression and enzyme activity associated with bad breath | 2019.12 |
6 | SCI | J Vet Dent. 2019;36(2):135-142. |
in vivo study | Effects of Weissella cibaria CMU on Halitosis and Calculus, Plaque, and Gingivitis Indices in Beagles | 2019.09 |
7 | SCI | Int J Mol Sci. 2019;20(11). | in vitro study | Safety Evaluation of Oral Care Probiotics Weissella cibaria CMU and CMS1 by Phenotypic and Genotypic Analysis | 2019.05 |
8 | KCI | Int J Oral Biol 2018;43(4):193-200. |
in vitro study | Effect of Natural Extracts on Oral Care Probiotics Weissella cibaria CMU and Periodontal Pathogens | 2018.12 |
9 | SCOPUS | Indian J Public Health Res&Dev. 2018;9(9):1163. |
Clinical trial | Clinical studies on the dental caries prevention effects of the ability of Weissella cibaria CMU to adhere to the oral cavity | 2018.10 |
10 | J. Milk Sci. Biotechnol. 2018;36(3):171-177. |
in vitro study | Enhancement of Viability of Weissella cibaria CMU by Low-Temperature Encapsulation | 2018.09 |
No | Citation | Journal | Research Level | Title | Date |
---|---|---|---|---|---|
11 | SCI | Molecules 2018;23(8):1984. |
in vitro study | Characterization of Antibacterial Cell-Free Supernatant from Oral Care Probiotic Weissella cibaria, CMU | 2018.08 |
12 | KCI | Korean J Vet Res. 2018;58(2):87-94. |
in vivo study | Oral malodor-reducing effects by oral feeding of Weissella cibaria CMU in Beagle dogs | 2018.05 |
13 | SCOPUS | Genome Announc. 2017;5(40). |
in vitro study | Complete Genome Sequences of Weissella cibaria Strains CMU, CMS1, CMS2, and CMS3 Isolated from Infant Saliva in South Korea | 2017.10 |
14 | SCI | Molecules. 2016;21(12). |
in vitro study | Comparative Study on the Characteristics of Weissella cibaria CMU and Probiotic Strains for Oral Care | 2016.12 |
15 | KCI | Chonnam Med J. 2012;48(3):159-63. |
in vitro study | Comparison of Temperature and Additives Affecting the Stability of the Probiotic Weissella cibaria | 2012.12 |
16 | KCI | J Bacterol Virol. 2011;41(1):17–26. |
in vitro study | Effect of Weissella cibaria on Fusobacterium nucleatum-induced Interleukin-6 and Interleukin-8 Production in KB Cells | 2011.03 |
17 | KCI | J Bacterol Virol. 2009;39(4):1–11. |
in vitro study | Quantitative analysis of Weissella cibaria Against Periodontopathic Bacteria by Real-time PCR | 2009.12 |
18 | SCI | FEMS Microbiol Lett. 2009;292(1):33-41. |
in vitro study | Molecular characterization and expression analysis of the glucansucrase DSRWC from Weissella cibaria synthesizing a α(1→6)glucan | 2009.01 |
19 | SCI | Caries Res. 2006;40(5):418-25. |
in vitro study clinical trial |
Effect of Weissella cibaria Isolates on the Formation of Streptococcus mutans Biofilm | 2006.08 |
20 | SCI | J Clin Periodontol. 2006;33(3):226-32. |
in vitro study clinical trial |
Inhibitory effect of Weissella cibaria isolates on the production of volatile sulphur compounds | 2006.02 |
No | Citation | Journal | Research Level | Title | Date |
---|---|---|---|---|---|
21 | KCI | J Bacterol Virol. 2006;36(3):151–157. |
in vitro study | Adhesion of Weissella cibaria to the Epithelial Cells and Factors Affecting its Adhesion | 2006.09 |
22 | SCI | FEMS Microbiol Lett. 2005;253(2):323-9. |
in vitro study | Coaggregation ability of Weissella cibaria isolates with Fusobacterium nucleatum and their adhesiveness to epithelial cells | 2005.10 |
The research team in OraPharm studies not only oral diseases(halitosis, dental caries,
periodontitis, etc.),
but also other various diseases including a sore throat,
upper and lower respiratory diseases, and such.
We are well aware oral health is critical to one’s whole body health and healthy and happy life.
OraPharm continues researching to support everyone’s opportunities for a healthy life.